Bolt Biotherapeutics(DE:6LP0)
€5.180.00 (0.00%)
DE:6LP0
Bolt Biotherapeutics earnings date
€5.18
At close:0.00 (0.00%)
Bolt Biotherapeutics (6LP0) Q3 2022 Earnings Report
0 Followers
DE:6LP0 Q3 2022 EPS Results
- Actual EPS
- -EUR 10.52
- Consensus EPS
- -EUR 10.04
- Beat/Miss
- Missed by -EUR 0.48
- One Year Ago EPS
- -EUR 11.43
DE:6LP0 Q3 2022 Revenue Results
- Actual Revenue
- EUR 1.92M
- Expected Revenue
- EUR 898.08K
- Beat/Miss
- Beat by +EUR 1.02M
- YoY Revenue Growth
- +180.85%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/10/2022
- Time
- After Close
- Conference Call
- Thursday, November 10, 2022
DE:6LP0 Upcoming Earnings
Bolt Biotherapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6LP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -3.49- | -3.48 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -3.34-2.04 | -3.37 | 39.52% (+1.33) | |
| Aug 11, 2026 | 2026 (Q2) | -3.07-4.15 | -4.05 | -2.47% (-0.10) | |
| May 12, 2026 | 2026 (Q1) | -2.59-3.91 | -5.26 | 25.69% (+1.35) | |
| Mar 12, 2026 | 2025 (Q4) | -5.54-3.48 | -7.62 | 54.29% (+4.14) | |
| Nov 12, 2025 | 2025 (Q3) | -5.15-3.37 | -7.26 | 53.50% (+3.88) | |
| Aug 14, 2025 | 2025 (Q2) | -5.72-4.05 | -10.16 | 60.18% (+6.11) | |
| May 12, 2025 | 2025 (Q1) | -6.44-5.26 | -5.08 | -3.57% (-0.18) | |
| Mar 24, 2025 | 2024 (Q4) | -6.89-7.62 | -8.53 | 10.64% (+0.91) | |
| Nov 12, 2024 | 2024 (Q3) | -6.17-7.26 | -7.8 | 6.98% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

